ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Allergy Immunology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,690Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 85

$988K Total Retail Price of All Prescriptions

Rank: 1 out of 85

1,021 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
27% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Florida
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 1,021 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

14% of this provider’s 1,021 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Risky Drugs to Seniors

3% of this provider’s 5,279 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 47%.

Prescription Price

$114 was the average price of a prescription from this provider, compared to $137 among peers.

Prescriptions per Patient

9 is the average number of prescriptions (including refills) per patient, compared to an average of 6.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Florida
METHOTREXATE 1,136 873 1 6
HYDROXYCHLOROQUINE SULFATE 959 619 2 9
PREDNISONE 697 523 3 2
HYDROCODONE-ACETAMINOPHEN 669 243 S3 4 15
LEFLUNOMIDE 257 193 5 25
GABAPENTIN 234 124 6 27
TRAMADOL HCL 195 123 7 30
SULFASALAZINE 189 105 8 31
OXYCODONE HCL-ACETAMINOPHEN 159 90 S2 9 33
ALLOPURINOL 136 91 10 36
OXYCODONE-ACETAMINOPHEN 127 95 S2 11 40
MELOXICAM 118 77 12 45
MINOCYCLINE HCL 116 81 13 46
CYCLOBENZAPRINE HCL 113 52 R 14 47
LEUCOVORIN CALCIUM 110 72 15 48
AZATHIOPRINE 108 40 16 50
OMEPRAZOLE 100 50 17 11
ENBREL 93 29 18 53
CYMBALTA 88 39 19 56
CELEBREX 86 73 20 57
FLUTICASONE PROPIONATE 86 57 20 1
ZOLPIDEM TARTRATE 83 53 22 37
HUMIRA 81 39 23 59
ADVAIR DISKUS 80 47 24 4
CARISOPRODOL 79 27 R 25 29
PROAIR HFA 75 21 26 10
AZITHROMYCIN 73 56 27 24
FENTANYL 71 0 S2 28 62
ROPINIROLE HCL 69 32 29 64
ETODOLAC 68 22 30 65
LYRICA 64 34 31 69
AMITRIPTYLINE HCL 63 29 R 32 43
SULFASALAZINE DR 57 47 33 71
ALENDRONATE SODIUM 56 43 34 73
OXYCODONE HCL 55 18 S2 35 18
MYCOPHENOLATE MOFETIL 53 11 36 78
METHYLPREDNISOLONE 51 31 37 80
CALCITONIN-SALMON 51 40 37 80
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on March 12, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.